GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
136 hedge funds and large institutions have $1.22B invested in Global Blood Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 134 → 136 (+2)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
136
Holding in Top 10
5
Calls
$14.9M
Puts
$4.43M
Top Buyers
| 1 | +$41.1M | |
| 2 | +$13.4M | |
| 3 | +$10.3M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$9.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.62M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$17.3M | |
| 3 | -$11.9M | |
| 4 |
PC
PointState Capital
New York
|
-$7.67M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.11M |